Mobile

A 20 week multi-national, open-labelled, randomised, three-group parallel trial comparing administration of insulin detemir morning, insulin detemir evening and NPH insulin evening as add-on to oral a...

Update Il y a 4 ans
Reference: EUCTR2004-001461-18

A 20 week multi-national, open-labelled, randomised, three-group parallel trial comparing administration of insulin detemir morning, insulin detemir evening and NPH insulin evening as add-on to oral antidiabetic drug(s) in subjects with type 2 diabetes

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective is to compare the glycaemic control, measured as HbA1c, of insulin detemir given once daily with that of NPH insulin given once daily as add-on to current OAD treatment, in subjects with type 2 diabetes after a 20 week treatment period

Inclusion criteria

  • Type 2 Diabetes

Links